Cambridge, MA, United States of America

Ryan Spangler

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.3

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ryan Spangler

Introduction

Ryan Spangler is a notable inventor based in Cambridge, MA, who has made significant strides in the field of cancer research. With a total of three patents to his name, his work focuses on developing therapeutic methods for various types of cancers. His innovative approaches aim to improve diagnosis and treatment options for patients suffering from these diseases.

Latest Patents

Ryan Spangler's latest patents include groundbreaking research on cancers associated with the loss of chromosome 16Q and low expression of metallothionein proteins. This patent outlines compositions and methods for diagnosing and treating cancers, particularly those that exhibit specific genetic markers. The disclosure highlights the use of three known drugs—disulfiram, elesclomol, and thiram—as potential therapeutic agents for targeting cancer cells characterized by these genetic alterations.

Another significant patent involves the use of aryl hydrocarbon receptor (AHR) activator compounds as cancer therapeutics. This research focuses on cancers that show elevated expression of FOXA1 and its gene targets, including certain breast, liver, and prostate cancers. The patent details the use of adenosine receptor antagonists, such as CGS-15943, MRS-1220, and SCH-58261, in targeting cancer cells through AHR activation.

Career Highlights

Throughout his career, Ryan Spangler has worked with prestigious organizations, including the Broad Institute, Inc. and Dana-Farber Cancer Institute. His contributions to cancer research have been instrumental in advancing therapeutic strategies and improving patient outcomes.

Collaborations

Ryan has collaborated with esteemed colleagues, including Steven Corsello and Rohith Nagari, to further enhance the impact of his research in the field of oncology.

Conclusion

Ryan Spangler's innovative work in cancer research exemplifies the importance of scientific advancements in improving treatment options for patients. His patents reflect a commitment to addressing critical challenges in cancer therapy and diagnosis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…